Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$25.44 - $59.78 $293,119 - $688,785
-11,522 Reduced 79.8%
2,917 $79,000
Q3 2022

Oct 25, 2022

BUY
$43.66 - $61.0 $294,705 - $411,750
6,750 Added 87.79%
14,439 $777,000
Q2 2022

Aug 04, 2022

BUY
$28.82 - $77.35 $62,395 - $167,462
2,165 Added 39.19%
7,689 $310,000
Q1 2022

Apr 14, 2022

BUY
$48.25 - $100.49 $157,488 - $327,999
3,264 Added 144.42%
5,524 $365,000
Q4 2021

Jan 18, 2022

BUY
$88.71 - $120.43 $198,621 - $269,642
2,239 Added 10661.9%
2,260 $226,000
Q2 2021

Jul 19, 2021

SELL
$109.77 - $165.68 $348,958 - $526,696
-3,179 Reduced 99.34%
21 $2,000
Q4 2019

Feb 06, 2020

SELL
$59.49 - $82.78 $132,543 - $184,433
-2,228 Reduced 41.05%
3,200 $250,000
Q3 2019

Oct 28, 2019

BUY
$62.59 - $110.3 $339,738 - $598,708
5,428 New
5,428 $346,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.